Antihypertensive peptide and application thereof

A blood pressure-lowering peptide and a blood pressure-lowering technology, applied in the blood pressure-lowering peptide and its application field, can solve the problems of increasing blood urea nitrogen and creatinine, restricting the use of hypertensive patients, etc.

Active Publication Date: 2016-10-26
JILIN AGRICULTURAL UNIV
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although this type of ACE inhibitory drugs can lower blood pressure clinically, they also bring many side effects, such as neurogenic edema, renal sclerosis, hypokalemia, etc., especially have adverse effects on patients with impaired renal function, which can cause blood urea Nitrogen and creatinine increases, limiting use in hypertensive patients

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antihypertensive peptide and application thereof
  • Antihypertensive peptide and application thereof
  • Antihypertensive peptide and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] The following examples are to further illustrate the present invention, rather than limit the present invention.

[0011] 1. Experimental Materials and Instruments

[0012] YLVR (purity 80%, synthesized by Beijing Zhongke Yaguang Biotechnology Co., Ltd.), captoril (Captoril), spontaneously hypertensive rats (Spontaneously hypertensive rats, SHR) 9-10 weeks, weighing 220-270 grams , SPF grade, purchased from Beijing Weitong Lihua Experimental Animal Technology Co., Ltd.

[0013] 2 Experimental method:

[0014] 2.1 Grouping of rats

[0015] The temperature of the raising environment for the rats is 22°C±1°C, the relative humidity is 60%±5%, the light time is 12 hours a day, and light and darkness are alternated. The lighting time is from 7:30 to 19:30. Before carrying out the test, the rats need a week to adapt to the new environment, single-cage feeding, free access to food and water, standard feed feeding, and daily tracking and statistics of food intake and water i...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Antihypertensive peptide and application thereof belong to the technical field of antihypertensive peptides; the antihypertensive peptide has an amino acid sequence of YLVR (Lyr, Leu, Val and Arg). Animal experiments discover that antihypertensive peptide YLVR is antihypertensive for a spontaneously hypertensive rat (SHR), has no significant effect on the weight of the SHR, has no significant effect on the heart rate of the SHR, has no effect on the normal growth of the rat, and may be referenced for synthesis of hypertension therapeutics for preparing antihypertensive drugs.

Description

technical field [0001] The invention belongs to the technical field of hypotensive peptides, in particular to a hypotensive peptide and its application. Background technique [0002] Angiotensin-converting enzyme-I (ACE, EC 3.4.15.1) is a Zn-containing 2+ Carboxydipeptidase of the prosthetic group is a key enzyme of the renin-angiotensin-aldosterone system (RAS), which converts angiotensin I into angiotensin II through hydrolysis, and at the same time, ACE can also blunt Bradykinin, both of which can lead to vasoconstriction, which can lead to high blood pressure. Therefore, ACE is considered to be an important factor causing hypertension. According to the structure-activity relationship, the design of small molecules to replace AngI and combine with the active center of ACE is the design principle of antihypertensive drugs. Captopril is an ideal ACE inhibitor designed by people, and on this basis, enalapril and lisinopril are further synthesized, which are currently the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K5/107A61K38/07A61P9/12
CPCA61K38/00C07K5/1016
Inventor 闵伟红刘春雷李鸿梅方丽王辑
Owner JILIN AGRICULTURAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap